Screener
Monopar Therapeutics MNPR Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from Monopar Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Monopar Therapeutics’s 10-Q, filed May 14, 2026. Open the filing →
- Filed
- May 14, 2026, 2:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-016982
FAQ
- What is Monopar Therapeutics's price / book?
- Monopar Therapeutics (MNPR) reported price / book of 2.7× in Q1 2026.
- How has Monopar Therapeutics's price / book changed year-over-year?
- Monopar Therapeutics's price / book decreased by 34.7% year-over-year, from 4.1× to 2.7×.
- What is the long-term trend for Monopar Therapeutics's price / book?
- Over 5 years (2020 to 2025), Monopar Therapeutics's price / book has grown at a -33.6% compound annual growth rate (CAGR), from 24.6× to 3.2×.
- What does price / book mean?
- Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.
Ask your AI about Monopar Therapeutics's price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude